Unicycive Therapeutics, Inc. (UNCY)

NASDAQ: UNCY · IEX Real-Time Price · USD

1.120

-0.100 (-8.20%)

At close: Apr 30, 2024, 4:00 PM

1.160

+0.040 (3.57%)

Pre-market: May 1, 2024, 8:02 AM EDT

Unicycive Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	39	30	8	31	-	-
Market Cap Growth	-	270.11%	-73.58%	-	-	-
Enterprise Value	30	21	8	15	3	0
PE Ratio	-0.96	-0.96	-0.45	-3.08	-	-
PB Ratio	-7.92	-7.92	-17.48	1.87	-	-
P/FCF Ratio	-1.65	-1.65	-0.52	-5.32	-	-
P/OCF Ratio	-1.65	-1.65	-0.52	-5.35	-	-
EV/EBITDA Ratio	-0.70	-0.70	-0.44	-1.55	-1.24	-0.22
EV/EBIT Ratio	-0.70	-0.70	-0.43	-1.55	-1.24	-0.22
EV/FCF Ratio	-1.16	-1.16	-0.50	-2.51	-1.72	-0.38
Debt / Equity Ratio	-0.21	-0.21	-0.33	0.02	-0.94	-0.52
Debt / EBITDA Ratio	-0.03	-0.03	-0.01	-0.03	-1.24	-0.23
Debt / FCF Ratio	-0.04	-0.04	-0.01	-0.05	-1.72	-0.39
Quick Ratio	0.55	0.55	0.14	7.88	0	0.02
Current Ratio	0.76	0.76	0.81	8.75	0.07	0.02
Interest Coverage	-371.49	-371.49	-3008.67	-14.95	-8.28	-14.58
Return on Equity (ROE)	360.30%	360.30%	-264.50%	-143.70%	127.40%	-
Return on Assets (ROA)	-150.10%	-150.10%	-173.80%	-100.30%	-2030.50%	-
Return on Capital (ROIC)	711.17%	711.17%	6110.29%	-53.47%	1286.62%	462.97%
Earnings Yield	-80.69%	-104.16%	-221.63%	-32.48%	-	-
FCF Yield	-47.00%	-60.67%	-192.11%	-18.79%	-	-
Buyback Yield / Dilution	-62.98%	-62.98%	-28.96%	-37.37%	-4.68%	-
Total Shareholder Return	-62.98%	-62.98%	-28.96%	-37.37%	-4.68%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).